Quick Answer
Cocrystal Pharma, Inc. reported Shares Outstanding of 13.78 million shares for fiscal year 2025.
Cocrystal Pharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 13.78M | +35.5% |
| 2024 | 10.17M | +0.0% |
| 2023 | 10.17M | +24.9% |
| 2022 | 8.14M | +0.0% |
| 2021 | 8.14M | -88.4% |
| 2020 | 70.44M | +100.4% |
| 2019 | 35.15M | +17.4% |
| 2018 | 29.94M | +23.3% |
| 2017 | 24.27M | +2.0% |
| 2016 | 23.80M | -96.6% |
| 2015 | 694.40M | +566781.6% |
| 2014 | 122,494 | — |
| 2013 | 0 | -100.0% |
| 2012 | 63.14M | +14.4% |
| 2011 | 55.18M | +23.3% |
| 2010 | 44.75M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 13.04M | +28.2% | +28.2% |
| June 30, 2025 | 10.17M | +0.0% | +0.0% |
| March 31, 2025 | 10.17M | +0.0% | +0.0% |
| December 31, 2024 | 10.17M | +0.0% | +0.0% |
| September 30, 2024 | 10.17M | +0.0% | +0.0% |
| June 30, 2024 | 10.17M | +0.0% | +0.0% |
| March 31, 2024 | 10.17M | +24.9% | +0.0% |
| December 31, 2023 | 10.17M | +24.9% | +0.0% |
- Cocrystal Pharma, Inc. showed an increase of +35.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Cocrystal Pharma, Inc.’s shares outstanding has declined by 69.2% (from 44.75 million shares to 13.78 million shares).
- The most recent figure is from Cocrystal Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: